Dubnovitsky et al., 2000 - Google Patents

Expression, refolding, and ferritin-binding activity of the isolated VL-domain of monoclonal antibody F11

Dubnovitsky et al., 2000

View PDF
Document ID
14043819566443355399
Author
Dubnovitsky A
Kravchuk Z
Chumanevich A
Cozzi A
Arosio P
Martsev S
et al.
Publication year
Publication venue
BIOCHEMISTRY C/C OF BIOKHIMIIA

External Links

Snippet

Expression of the VL domain of mouse monoclonal antibody F11 to human spleen ferritin in Escherichia coli cells is associated with the formation of insoluble protein aggregates (inclusion bodies). The aggregates were solubilized in the presence of guanidine …
Continue reading at www.protein.bio.msu.ru (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48369—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment

Similar Documents

Publication Publication Date Title
Johanson et al. Chemical characterization and purification of the beta subunit of the DNA polymerase III holoenzyme from an overproducing strain.
Bird et al. Single-chain antigen-binding proteins
US6207390B1 (en) Methods for the use of reduced affinity streptavidin
JP3634358B2 (en) Protein-based transport system
Yang et al. Tailoring structure–function and pharmacokinetic properties of single‐chain Fv proteins by site‐specific PEGylation
US6121424A (en) Multivalent antigen-binding proteins
EP0483194B1 (en) IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST
JP3474574B2 (en) Recombinant disulfide stabilized polypeptide fragments with binding specificity
Kurucz et al. A bacterially expressed single-chain Fv construct from the 2B4 T-cell receptor.
JPH07501698A (en) Bivalent specific heterodimer
EP0617706A1 (en) Multivalent antigen-binding proteins
Sánchez et al. High cytoplasmic expression in E. coli, purification, and in vitro refolding of a single chain Fv antibody fragment against the hepatitis B surface antigen
AU2004274368B2 (en) Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens of low immunogenicity
Sazuka et al. DRG: a novel developmentally regulated GTP-binding protein
Tan et al. Engineering the isoelectric point of a renal cell carcinoma targeting antibody greatly enhances scFv solubility
US20050064509A1 (en) Use of templated self assembly to create novel multifunctional species
Dubnovitsky et al. Expression, refolding, and ferritin-binding activity of the isolated VL-domain of monoclonal antibody F11
Thompson et al. Development of an epitope tag for the gentle purification of proteins by immunoaffinity chromatography: application to epitope-tagged green fluorescent protein
US6395875B1 (en) Recombinant soluble adenovirus receptor
Hass et al. Preparation of synthetic polypeptide domains of carcinoembryonic antigen and their use in epitope mapping
Lee et al. Bacterial expression and in vitro refolding of a single-chain fv antibody specific for human plasma apolipoprotein B-100
Webster et al. Domain organization of the adenovirus preterminal protein
MacKenzie et al. The use of a monoclonal antibody specific for the N-terminal region of southern bean mosaic virus as a probe of virus structure
Böldicke et al. A new peptide-affinity tag for the detection and affinity purification of recombinant proteins with a monoclonal antibody
Prinsloo et al. In vitro refolding of recombinant human free secretory component using equilibrium gradient dialysis